U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 95

1.
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK)
Cindy L J Weinstein, Paula Sliwinska-Stanczyk, Tomas Hála, Marina Stanislav, Anjela Tzontcheva, Ruji Yao, Yuliya Berd, Sean P Curtis, George Philip
Rheumatology (Oxford) 2023 Nov; 62(11): 3601–3609. Published online 2023 Mar 15. doi: 10.1093/rheumatology/kead112
PMCID:
PMC10629786
ArticlePubReaderPDF–643KCite
2.
Comparison of clinical characteristics between adult-onset and juvenile-onset non-radiographic axial spondyloarthritis in Chinese patients: results from the COCAS cohort
Shu-Xin Huang, Hao-Guang Li, Hong-Jin Liang, Dan-Min Wang, Jian-Hua Peng, Feng-Cai Shen, Wei-Ping Li, Ling Lin, Zheng-Yu Xiao, Zhi-Duo Hou
Eur J Med Res. 2023; 28: 388. Published online 2023 Sep 28. doi: 10.1186/s40001-023-01387-x
PMCID:
PMC10537580
ArticlePubReaderPDF–1.4MCite
3.
Disease course of non-radiographic axial spondyloarthritis: Data from a long-term retrospective observational cohort
Oh Chan Kwon, Yong-Gil Kim, Min-Chan Park
PLoS One. 2023; 18(6): e0288153. Published online 2023 Jun 30. doi: 10.1371/journal.pone.0288153
PMCID:
PMC10313044
ArticlePubReaderPDF–357KCite
4.
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
Juergen Braun, Ricardo Blanco, Helena Marzo-Ortega, Lianne S. Gensler, Filip Van den Bosch, Stephen Hall, Hideto Kameda, Denis Poddubnyy, Marleen van de Sande, Désirée van der Heijde, Tingting Zhuang, Anna Stefanska, Aimee Readie, Hanno B. Richards, Atul Deodhar
Arthritis Res Ther. 2023; 25: 80. Published online 2023 May 16. doi: 10.1186/s13075-023-03051-5
PMCID:
PMC10186767
ArticlePubReaderPDF–1.6MCite
5.
Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2
Uta Kiltz, Mitsumasa Kishimoto, Jessica A. Walsh, Percival Sampaio-Barros, Manish Mittal, Christopher D. Saffore, Peter Wung, Fabiana Ganz, Ana Biljan, Denis Poddubnyy
Rheumatol Ther. 2023 Aug; 10(4): 887–899. Published online 2023 May 16. doi: 10.1007/s40744-023-00550-4
PMCID:
PMC10186301
ArticlePubReaderPDF–612KCite
6.
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy
Paolo Angelo Cortesi, Carla Fornari, Paolo Gisondi, Florenzo Iannone, Ippazio Cosimo Antonazzo, Elisabetta Aloisi, Martina Fiocchi, Daniela Ritrovato, Lorenzo Giovanni Mantovani
Pharmacoecon Open. 2023 May; 7(3): 405–416. Published online 2023 Mar 16. doi: 10.1007/s41669-023-00404-3
PMCID:
PMC10169960
ArticlePubReaderPDF–1.4MCite
7.
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons
Nurullah Akkoç, Carlos H. Arteaga, Simone E. Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J. Mease
Rheumatol Ther. 2023 Apr; 10(2): 307–327. Published online 2023 Jan 12. doi: 10.1007/s40744-022-00522-0
PMCID:
PMC10011375
ArticlePubReaderPDF–858KCite
8.
A tale about an unusual cause of pygalgia in non‐radiographic axial spondyloarthritis
Rim Dhahri, Hiba Bettaieb, Maroua Slouma, Yasmine Khrifech, Youssef Mallat, Khalil Amri, Ahmed Harbaoui, Leila Metoui, Imen Gharsallah, Bassem Louzir
Clin Case Rep. 2023 Feb; 11(2): e6954. Published online 2023 Feb 10. doi: 10.1002/ccr3.6954
PMCID:
PMC9914083
ArticlePubReaderPDF–1.3MCite
9.
Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study
Philip C. Robinson, Walter P. Maksymowych, Lianne S. Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha de Peyrecave, Atul Deodhar
ACR Open Rheumatol. 2022 Sep; 4(9): 794–801. Published online 2022 Jun 22. doi: 10.1002/acr2.11469
PMCID:
PMC9469479
ArticlePubReaderPDF–1.1MCite
10.
Pearls and Pitfalls in Diagnosing Non-Radiographic Axial Spondyloarthritis
Styliani Tsiami, Xenofon Baraliakos
Mediterr J Rheumatol. 2022 Mar; 33(Suppl 1): 109–114. Published online 2022 Apr 15. doi: 10.31138/mjr.33.1.109
PMCID:
PMC9450190
ArticlePubReaderPDF–4.6MCite
11.
The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis
Qian He, Jing Luo, Jiaqi Chen, Jianying Yang, Chuanhui Yao, Caiqin Xu, Qingwen Tao
Health Qual Life Outcomes. 2022; 20: 116. Published online 2022 Jul 30. doi: 10.1186/s12955-022-02026-5
PMCID:
PMC9338652
ArticlePubReaderPDF–1.9MCite
12.
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non‐radiographic axial spondyloarthritis)
Féline PB Kroon, Lennart RA van der Burg, Sofia Ramiro, Robert BM Landewé, Rachelle Buchbinder, Louise Falzon, Désirée van der Heijde, Cochrane Musculoskeletal Group
Cochrane Database Syst Rev. 2015 Jul; 2015(7): CD010952. Published online 2015 Jul 17. doi: 10.1002/14651858.CD010952.pub2
PMCID:
PMC8942090
ArticlePubReaderPDF–1.7MCite
13.
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study
Désirée van der Heijde, Lianne S Gensler, Walter P Maksymowych, Robert Landewé, Martin Rudwaleit, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri, Bengt Hoepken, Atul Deodhar
RMD Open. 2022; 8(1): e002138. Published online 2022 Mar 16. doi: 10.1136/rmdopen-2021-002138
PMCID:
PMC8928377
ArticlePubReaderPDF–2.0MCite
14.
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Steven L. Truong, Tim McEwan, Paul Bird, Irwin Lim, Nivene F. Saad, Lionel Schachna, Andrew L. Taylor, Philip C. Robinson
Rheumatol Ther. 2022 Feb; 9(1): 1–24. Published online 2021 Dec 28. doi: 10.1007/s40744-021-00416-7
PMCID:
PMC8814294
ArticlePubReaderPDF–884KCite
15.
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
Adrian Ciurea, Seraphina Kissling, Kristina Bürki, Xenofon Baraliakos, Manouk de Hooge, Monika Hebeisen, Eleftherios Papagiannoulis, Pascale Exer, René Bräm, Michael J Nissen, Burkhard Möller, Diego Kyburz, Michael Andor, Oliver Distler, Almut Scherer, Raphael Micheroli
RMD Open. 2022; 8(1): e002067. Published online 2022 Feb 2. doi: 10.1136/rmdopen-2021-002067
PMCID:
PMC8811599
ArticlePubReaderPDF–625KCite
16.
Test–retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis
Anne Boel, Victoria Navarro-Compán, Désirée van der Heijde
RMD Open. 2021; 7(3): e001839. Published online 2021 Dec 10. doi: 10.1136/rmdopen-2021-001839
PMCID:
PMC8666887
ArticlePubReaderPDF–356KCite
17.
Risk factors for progression of juvenile-onset non-radiographic axial spondyloarthritis to juvenile-onset ankylosing spondylitis: a nested case–control study
Hao-Guang Li, Dan-Min Wang, Feng-Cai Shen, Shu-Xin Huang, Zhi-Duo Hou, Ling Lin, Zheng-Yu Xiao
RMD Open. 2021; 7(3): e001867. Published online 2021 Dec 3. doi: 10.1136/rmdopen-2021-001867
PMCID:
PMC8647561
ArticlePubReaderPDF–639KCite
18.
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
María Aparicio, Carlos A. Guillén-Astete, Clementina López-Medina, Carlos Sastre, Fernando J. Rodríguez Martínez
Rheumatol Ther. 2022 Feb; 9(1): 73–94. Published online 2021 Nov 27. doi: 10.1007/s40744-021-00400-1
PMCID:
PMC8627156
ArticlePubReaderPDF–2.7MCite
19.
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
Walter P. Maksymowych, Thomas Kumke, Simone E. Auteri, Bengt Hoepken, Lars Bauer, Martin Rudwaleit
Arthritis Res Ther. 2021; 23: 274. Published online 2021 Oct 29. doi: 10.1186/s13075-021-02650-4
PMCID:
PMC8556993
ArticlePubReaderPDF–2.1MCite
20.
Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks
Atul Deodhar, Philip Mease, Helena Marzo-Ortega, Theresa Hunter, David Sandoval, Andris Kronbergs, Steven Lauzon, Ann Leung, Victoria Navarro-Compán
BMC Rheumatol. 2021; 5: 50. Published online 2021 Sep 25. doi: 10.1186/s41927-021-00218-y
PMCID:
PMC8464085
ArticlePubReaderPDF–916KCite

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center